Marker size reflects company revenue scale, while color identifies headquarters region. This reveals where major pharmaceutical corporate power is concentrated globally.
This map separates pharmaceutical export strength, import dependence, and end-market size, helping distinguish where medicines are produced, traded, and absorbed.
The 15 largest firms in the dashboard by revenue scale.
Regional concentration of revenue among the featured firms.
Number of featured companies headquartered in each region.
Exports, imports, and estimated consumption share across regions.
Europe benefits from deep industrial clustering, biologics capability, advanced regulatory ecosystems, and long-established cross-border pharmaceutical trade networks.
North America remains the largest medicine end-market because of high per-capita spending, premium pricing, insurance depth, and faster uptake of innovative therapies.
Surplus is not only a production question. It is also shaped by uneven demand, purchasing power, reimbursement systems, regulatory access, and global distribution pathways.
Search by company, brands, country, or region. Designed for desktop, tablet, and mobile browsing.
| Rank | Company | Ticker | HQ Country | Region | Revenue (USD bn) | Share of Top-30 (%) | Top Brands | Primary Consumption Regions | Strategic Note |
|---|